Namenda Buyers Say Product Hopping Class Action Has Legs
Drug wholesalers accusing Actavis and Merz of trying to stall the release of a generic version of the Alzheimer's treatment Namenda urged a New York federal judge Friday not to toss...To view the full article, register now.
Already a subscriber? Click here to view full article